European Respiratory Society International Conference, 2016
ExCeL Conference Centre, London, United Kingdom
The Hellenic Cystic Fibrosis Association was in London for the European Respiratory Society (ERS) International Congress, which was held at the ExCeL Conference Centre. The Congress was attended by over 22,000 delegates and over 40 patient associations were represented.
The ERS International Congress is held annually to cover the most important news and developments relating to the whole spectrum of respiratory diseases, including tuberculosis, lung cancer, pneumonia, cystic fibrosis, COPD and asthma. This year, for the first time, a “Patient Association Liaison Day” was held by the European Lung Foundation – ELF as part of this annual conference.
During the ELF Patient Association Liaison Day, Dimitris Kontopidis presented with a poster the key points for the effectiveness of the “Each Breath” awareness campaign of the Panhellenic Association for Fibrous Cystic Disease. He also participated with a presentation at the “World Village” entitled “Each Breath- an effective awareness campaign – CF Patients in Power” where he further analyzed the elements that led to the widespread success of the campaign. He also participated in a debate on the cooperation between patient associations and health scientists and in the Patient Advisory Committee where issues concerning patient associations at European level were discussed. The latter two were attended by representatives and patients from the UK, Poland, Switzerland, Ireland, Romania, Spain, Switzerland, Ireland, Romania and other European countries.
From the Greek Cystic Fibrosis Scientific Community, Elpida Hatziagorou and Ioannis Vogiatzis attended the Conference with presentations, speeches and posters.
“Each Breath- an effective awareness campaign – CF Patients in Power” was the presentation at the “World Village” of the ERS International Conference in London by the President of the Panhellenic Cystic Fibrosis Association Dimitris Kontopidis.
Elpida Hatziagorou and Ioannis Vogiatzis attended with presentations representing the Greek scientific community at the largest European Respiratory Society Conference with more than 22.000 participants and over 40 patient associations.